Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression.
BACKGROUND
The higher prevalence and cost of depression for women compared with men and the possible gender differences in treatment response demand the inclusion of women in clinical trials of depression treatments. The 1993 National Institutes of Health (NIH) Revitalization Act set a new standard, requiring investigators to consider the inclusion of women and analyze outcomes by gender, yet compliance with these standards in depression research has not been examined systematically. The purpose of this study is to examine the inclusion of women and gender-specific analyses in recent randomized clinical trials (RCTs) for depression.


METHODS
RCTs were identified through a MEDLINE search for trials published between January 1 and December 31, 2007, and a Clinicaltrials.gov search of self-identified interventional studies to treat depression.


RESULTS
Of the 150 RCTs for depression published in 2007, 15% did not report the gender composition of their sample, 50% of studies did not analyze outcomes by gender, and 12% controlled for gender but did not analyze for gender differences. Of the 768 trials reviewed on Clinicaltrials.gov, 89% reported recruiting male and female participants, yet <1% reported an intention to analyze results by gender.


CONCLUSIONS
Many recent studies of depression treatments include women but do not examine outcomes by gender. Understanding how women differ from men in response to treatment is critical for enhancing treatment efficacy for the greatest number of adults with depression.
Weinberger
Andrea H
AH
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA. andrea.weinberger@yale.edu
McKee
Sherry A
SA
Mazure
Carolyn M
CM
D000328:Adult; D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012737:Sex Factors
J Psychiatr Res. 2009 Feb;43(5):503-11
18752809
Am J Psychiatry. 2003 Sep;160(9):1643-50
12944340
Am J Psychiatry. 2000 Sep;157(9):1445-52
10964861
Public Health Rep. 1985 Jan-Feb;100(1):73-106
3918328
Mayo Clin Proc. 2007 Feb;82(2):166-70
17290722
Int Clin Psychopharmacol. 2005 Jan;20(1):1-7
15602108
Arch Gen Psychiatry. 2004 Nov;61(11):1107-15
15520358
Am J Psychiatry. 1994 Apr;151(4):500-5
8147447
Clin Pharmacol Ther. 2005 Nov;78(5):445-52
16321610
Arch Gen Psychiatry. 1992 Oct;49(10):831-4
1417437
JAMA. 1990 Nov 21;264(19):2524-8
2146410
Am J Addict. 2009 Jan-Feb;18(1):21-8
19219662
J Womens Health Gend Based Med. 2000 Jun;9(5):495-504
10883941
Clin Pharmacokinet. 2002;41(5):329-42
12036391
J Occup Environ Med. 2008 Apr;50(4):468-75
18404020
Nurs Res. 2004 Jul-Aug;53(4):237-42
15266162
Am J Psychiatry. 1992 May;149(5):587-95
1575248
J Womens Health (Larchmt). 2006 Dec;15(10):1123-31
17199453
Am J Psychiatry. 2004 Feb;161(2):370-2
14754791
J Clin Psychiatry. 2003 Dec;64(12):1465-75
14728109
J Affect Disord. 2007 Feb;98(1-2):29-43
16952399
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
8279933
Clin Pharmacokinet. 1997;32 Suppl 1:1-21
9068931
Fed Regist. 1993 Jul 22;58(139):39406-16
11645233
J Affect Disord. 1993 Oct-Nov;29(2-3):85-96
8300981
Gend Med. 2006 Jun;3(2):93-109
16860269
J Womens Health Gend Based Med. 2001 Oct;10(8):757-64
11703888
JAMA. 2003 Jun 18;289(23):3095-105
12813115